Literature DB >> 23528018

The experience of chemotherapy-induced alopecia for Australian women with ovarian cancer.

V Jayde1, M Boughton, P Blomfield.   

Abstract

This article describes the experience of chemotherapy-induced alopecia. Data resulted from an ongoing study, which sought to explore the experience of Australian women with a primary diagnosis of ovarian cancer. Phenomenological analysis of written accounts or interviews with 15 Australian women resulted in 13 of these 15 women giving priority to describing their experience of alopecia. The women described alopecia as the most distressing corporeal feature of the ovarian cancer experience. Factors which contributed to women's distress included: loss of sense of self and altered body image; reminder of their illness and potential for an early death; public statement about their private life, practical issues and re-growth. No literature was located, worldwide, which specifically explores the experience of alopecia for women with ovarian cancer. This article presents the first in-depth exploration of the experience of alopecia for Australian women with ovarian cancer. Insight gained from this study will inform understanding of the issues associated with alopecia for women with ovarian cancer and may facilitate the provision of optimal supportive care provided by health care professionals for female cancer patients with chemotherapy-induced alopecia.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23528018     DOI: 10.1111/ecc.12056

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  8 in total

1.  The role of pegylated liposomal doxorubicin in ovarian cancer: a meta-analysis of randomized clinical trials.

Authors:  Jean-Marie Gibson; Saeed Alzghari; Chul Ahn; Holly Trantham; Ninh M La-Beck
Journal:  Oncologist       Date:  2013-07-23

2.  Design, synthesis, and biological activity of TLR7-based compounds for chemotherapy-induced alopecia.

Authors:  Jincheng Yang; Kun Chen; Bin Wang; Liudi Wang; Shuya Qi; Weihua Wang
Journal:  Invest New Drugs       Date:  2019-07-04       Impact factor: 3.850

3.  Madarosis: a qualitative study to assess perceptions and experience of Australian patients with early breast cancer treated with taxane-based chemotherapy.

Authors:  K Smith; J Winstanley; F Boyle; A O'Reilly; M White; Y C Antill
Journal:  Support Care Cancer       Date:  2017-08-22       Impact factor: 3.603

4.  Barriers and enablers to implementing scalp cooling in Australia: a qualitative study of health professionals' attitudes to and experience with scalp cooling.

Authors:  Joanne M Shaw; Jane O'Brien; Susan Chua; Richard De Boer; Rachel Dear; Nicholas Murray; Fran Boyle
Journal:  Support Care Cancer       Date:  2017-08-29       Impact factor: 3.603

5.  Scalp cooling: a qualitative study to assess the perceptions and experiences of Australian patients with breast cancer.

Authors:  Joanne Shaw; Brandi Baylock; Amanda O'Reilly; Julie Winstanley; Lina Pugliano; Kerrie Andrews; Frances Boyle
Journal:  Support Care Cancer       Date:  2016-04-09       Impact factor: 3.603

6.  Familiarity, opinions, experiences and knowledge about scalp cooling: a Dutch survey among breast cancer patients and oncological professionals.

Authors:  Mijke Peerbooms; Corina Jg van den Hurk; Wim Pm Breed
Journal:  Asia Pac J Oncol Nurs       Date:  2015 Jan-Mar

7.  Giving A Face to Chemotherapy-Induced Alopecia: A Feasibility Study on Drawings by Patients.

Authors:  Kirsten van Alphen; Anne Versluis; Wouter Dercksen; Henk de Haas; Rieneke Lugtenberg; Jitske Tiemensma; Judith Kroep; Elizabeth Broadbent; Ad A Kaptein; Corina van den Hurk
Journal:  Asia Pac J Oncol Nurs       Date:  2020-03-30

8.  The Impact of the Perception of Chemotherapy-Induced Alopecia on Psychosocial Life.

Authors:  Emine Özüsağlam; Gülbeyaz Can
Journal:  Florence Nightingale J Nurs       Date:  2021-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.